George Warimwe

George Warimwe

University of Oxford

H-index: 33

Europe-United Kingdom

About George Warimwe

George Warimwe, With an exceptional h-index of 33 and a recent h-index of 27 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Infectious disease, Epidemiology, Vaccines.

His recent articles reflect a diverse array of research interests and contributions to the field:

Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines

Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data

A Customizable Suite of Methods to Sequence and Annotate Cattle Antibodies

Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial

SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro

Metagenomic analysis of coastal Kenya female Aedes aegypti mosquito RNA metaviromes reveal presence of diverse insect specific viruses

George Warimwe Information

University

Position

___

Citations(all)

9526

Citations(since 2020)

8625

Cited By

2476

hIndex(all)

33

hIndex(since 2020)

27

i10Index(all)

53

i10Index(since 2020)

50

Email

University Profile Page

University of Oxford

Google Scholar

View Google Scholar Profile

George Warimwe Skills & Research Interests

Infectious disease

Epidemiology

Vaccines

Top articles of George Warimwe

Title

Journal

Author(s)

Publication Date

Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines

The Lancet Infectious Diseases

Aitana Juan-Giner

George Warimwe

2024/2/6

Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data

Plos one

Jane Paula Nyandele

Ummi Abdul Kibondo

Fatuma Issa

Jean Pierre Van Geertruyden

George Warimwe

...

2023/9/14

A Customizable Suite of Methods to Sequence and Annotate Cattle Antibodies

Vaccines

Kristel Ramirez Valdez

Benjamin Nzau

Daniel Dorey-Robinson

Michael Jarman

James Nyagwange

...

2023/6/14

Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study

Influenza and Other Respiratory Viruses

Katherine E Gallagher

Joyce Nyiro

Charles N Agoti

Eric Maitha

James Nyagwange

...

2023/9

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial

Wellcome Open Research

Mainga Hamaluba

Samuel Sang

Benedict Orindi

Irene Njau

Henry Karanja

...

2023/4/24

SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022

Influenza and other respiratory viruses

E Wangeci Kagucia

Abdhala K Ziraba

James Nyagwange

Bernadette Kutima

Makobu Kimani

...

2023/9

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro

International Journal of Infectious Diseases

James Nyagwange

Bernadette Kutima

Kennedy Mwai

Henry K Karanja

John N Gitonga

...

2023/2/1

Metagenomic analysis of coastal Kenya female Aedes aegypti mosquito RNA metaviromes reveal presence of diverse insect specific viruses

Wellcome Open Research

Donwilliams O Omuoyo

Doris K Nyamwaya

Everlyn Kamau

James N Nyagwange

Henry K Karanja

...

2023/8/16

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

The Lancet Infectious Diseases

Aitana Juan-Giner

Maria L Namulwana

Derick Kimathi

Kyra H Grantz

Gamou Fall

...

2023/8/1

Temporal trends of dengue seroprevalence among children in coastal Kenya, 1998-2018: a longitudinal cohort study

medRxiv

Henry K Karanja

Benedict Orindi

John N Gitonga

Daisy Mugo

Kennedy Mwai

...

2023

Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya

Journal of virus eradication

Louise O Downs

Cori Campbell

Michael Abouyannis

Mark Otiende

Melissa Kapulu

...

2023/12/1

Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial

The Lancet Infectious Diseases

Daniel Jenkin

Daniel Wright

Pedro M Folegatti

Abigail Platt

Ian Poulton

...

2023/8/1

The global burden of Chikungunya fever among children: A systematic literature review and meta-analysis

Doris K Nyamwaya

Samuel M Thumbi

Philip Bejon

George M Warimwe

Jolynne Mokaya

2022/12/21

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan …

Journal of Clinical Virology

James Nyagwange

Bernadette Kutima

Kennedy Mwai

Henry K Karanja

John N Gitonga

...

2022/1/1

Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014–2018: A cohort study

PLoS Medicine

Doris K Nyamwaya

Mark Otiende

Lilian Mwango

Symon M Kariuki

Berrick Otieno

...

2022/5/12

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020–21

Plos one

Ruth K Lucinde

Daisy Mugo

Christian Bottomley

Angela Karani

Elizabeth Gardiner

...

2022/10/14

Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis

Zacchaeus Anywaine

Swaib Abubaker Lule

Christian Hansen

George Warimwe

Alison Elliott

2022/3/25

Kinetics of naturally induced binding and neutralizing anti-SARS-CoV-2 antibody levels and potencies among Kenyan patients with diverse grades of COVID-19 severity

medRxiv

John Kimotho

Yiakon Sein

Shahin Sayed

Reena Shah

Kennedy Mwai

...

2022/10/5

Seroprevalence of antibodies to severe acute respiratory syndrome coronavirus 2 among healthcare workers in Kenya

Clinical Infectious Diseases

Anthony O Etyang

Ruth Lucinde

Henry Karanja

Catherine Kalu

Daisy Mugo

...

2022/1/15

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021

PLOS global public health

Anthony O Etyang

Ifedayo Adetifa

Richard Omore

Thomas Misore

Abdhalah K Ziraba

...

2022/8/18

See List of Professors in George Warimwe University(University of Oxford)

Co-Authors

H-index: 104
Sarah C Gilbert

Sarah C Gilbert

University of Oxford

H-index: 74
arnab pain

arnab pain

King Abdullah University of Science and Technology

H-index: 56
Greg Fegan

Greg Fegan

Swansea University

academic-engine